Inventor · disambiguated record
Kirk Dinehart
Also filed as: DINEHART KIRK · DINEHART KIRK RAYMOND
8 granted patents·11 pending applications·267 citations·filing 1999–2024
89Inventor score
Top patents by PatentIndex Score
19 records- 0197US10646481B2Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2016·Granted May 12, 2020·21 cites·26 claims
- 0296US11564916B2Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2020·Granted Jan 31, 2023·7 cites·40 claims
- 0395US9045425B2Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideVERTEX PHARMA·Filed 2014·Granted Jun 2, 2015·63 cites·27 claims
- 0494US11155533B2Crystalline forms and compositions of CFTR modulatorsVERTEX PHARMA·Filed 2020·Granted Oct 26, 2021·10 cites·13 claims
- 0593US10654829B2Crystalline forms and compositions of CFTR modulatorsVERTEX PHARMA·Filed 2018·Granted May 19, 2020·21 cites·23 claims
- 0693US8674108B2Solid forms of N-[2,4-bis(1,1-dimethylethy)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamideLUISI BRIAN·Filed 2012·Granted Mar 18, 2014·76 cites·28 claims
- 0784US6248335B1Stabilized oral pharmaceutical composition containing iodide and iodate and methodSYMBOLLON CORP·Filed 1999·Granted Jun 19, 2001·69 cites·13 claims
- 0866US2010074949A1Pharmaceutical composition and administration thereofROWE WILLIAM·Filed 2009·Application pending·0 cites
- 0965US12458635B2Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2022·Granted Nov 4, 2025·0 cites·17 claims
- 1062US2025186419A1Dosing regimens for treating painVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 1159US2014112988A1Pharmaceutical Composition and Administrations ThereofVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 1257US2014315948A1Pharmaceutical Composition and Administrations ThereofVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 1352US2012258983A1Pharmaceutical Composition and Administrations ThereofROWE WILLIAM·Filed 2012·Application pending·0 cites
- 1449US2015065439A1Pharmaceutical compositionsVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 1548US2013274180A1Pharmaceutical CompositionsVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 1647US2010256184A1Pharmaceutical composition and administrations thereofVERTEX PHARMA·Filed 2010·Application pending·0 cites
- 1745US2024285596A1Solid dosage forms and dosing regimens comprising (2r,3s,4s,5r)-4-[[3-(3,4-difluoro-2-methoxy-phenyl)-4,5-dimethyl-5-(trifluoromethyl) tetrahydrofuran-2-carbonyl]amino]pyridine-2-carboxamideVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 1844US2006089385A1Pharmaceutical compositionsCUI YONG·Filed 2005·Application pending·0 cites
- 1939US2012220625A1Pharmaceutical composition and administrations thereofROWE WILLIAM·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kirk Dinehart files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →